Migraine Newswire (Page 9)

Migraine Newswire (Page 9)

Comprehensive Real-Time News Feed for Migraine. (Page 9)

Results 161 - 180 of 835 in Migraine

  1. Zogenix (ZGNX) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPSRead the original story

    Nov 9, 2015 | AmericanBankingNews.com

    ... needle-free delivery system. Sumavel DosePro provides the administration of sumatriptan for the acute treatment of migraine and cluster headache. The Company sells Sumavel DosePro to pharmacies wholesale pharmaceutical distributors and hospitals. ...

    Comment?

  2. Impax Laboratories Stock Price Up 7.5% Following Strong EarningsRead the original story

    Nov 9, 2015 | AmericanBankingNews.com

    ... participated in the selling and distribution of Zomig (zolmitriptan) merchandises, indicated for the treatment of migraine head aches. Receive News & Ratings for Impax Laboratories Daily - Enter your email address below to receive a concise daily ...

    Comment?

  3. Pernix Therapeutics: $3.25 A Share Is Too CheapRead the original story w/Photo

    Nov 9, 2015 | Seeking Alpha

    ... second quarter of 2015. Revenue from Silenor increased 21% to $5.1 million year-over-year this quarter. This is a migraine treatment that Pernix acquired from GlaxoSmithKline (NYSE: GSK ) in the second half of 2014. It is a large market that ...

    Comment?

  4. A Daith of EvidenceRead the original story w/Photo

    Nov 5, 2015 | New Urban Legends

    I'd like to know if there's any truth to the suggestion that Daith piercings might help relieve migraines. As many as one in five Americans suffer from chronic migraine headaches, an episodic condition exacerbated by a lack of consistent treatment options.

    Comment?

  5. Doctors Exploring How Some Medications Can Treat Seemingly Unrelated AilmentsRead the original story w/Photo

    Nov 4, 2015 | CBS Local

    ... seem unrelated. Dr. Andrea Synowiec, of Allegheny General Hospital's neurology unit, uses the common ailment of a migraine as an example. "There are so many people who suffer from migraines, and the medicines that treat the headaches when they come ...

    Comment?

  6. Zosano Announces Positive Phase I Results For Its ZP-Triptan Patch...Read the original story

    Nov 2, 2015 | BioSpace

    Zosano Pharma Corporation , a clinical-stage specialty pharmaceutical company, today announced positive results from the Phase 1 clinical trial of its proprietary ZP-Triptan patch treatment for migraine. ZP-Triptan is a zolmitriptan-coated microneedle patch that is applied to an individual's upper arm to deliver zolmitriptan to the body.

    Comment?

  7. Free community health forum: Living with LymphedemaRead the original story w/Photo

    Oct 29, 2015 | The Weekly Packet

    ... g, lipedema and lipo-lipedema, localized edema at the residual limb after amputation, and may even be used to treat migraine headaches. Call 664-5337 or register online at mainehospital.org to reserve a seat.

    Comment?

  8. Antares Pharma to Host Third Quarter 2015 Operating and Financial Results Conference CallRead the original story w/Photo

    Oct 28, 2015 | GlobeNewswire

    Antares Pharma, Inc. today announced it will release its third quarter 2015 financial results and recent operating progress before the market opens on Thursday November 5, 2015, and host a webcast and conference call shortly thereafter at 8:30 a.m. ET to discuss the results. Eamonn P. Hobbs, President and Chief Executive Officer, will host the call.

    Comment?

  9. Alternative Methods of Dealing With MigrainesRead the original story w/Photo

    Oct 26, 2015 | Natural Holistic Health

    ... treating migraines but individuals have responded to the massages in a positive manner regarding satisfaction with migraine relief. Herbs and vitamin or mineral supplements such as feverfew, butterbur, riboflavin ( vitamin B -12), coenzyme Q10 , and ...

    Comment?

  10. Ten reasons you are overeatingRead the original story w/Photo

    Oct 26, 2015 | The New Zealand Herald

    ... as a tricyclic anti-depressant (TCA), which affects neurotransmitters of the brain. TCAs may also be used to treat migraine headaches. Doctors may prescribe a newer class of anti-depressant, called a selective serotonin re-uptake inhibitor (SSRI), ...

    Comment?

  11. Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q3 2015 Results - Earnings Call TranscriptRead the original story w/Photo

    Oct 22, 2015 | Seeking Alpha

    ... are also advancing three additional clinical programs rHIgM22 for remyelination in MS, CVT-427 for relief of acute migraine and cimaglermin alfa for heart failure. Returning to the late stage pipeline, CVT-301 is one of our most advanced programs. ...

    Comment?

  12. Zogenix Given Consensus Recommendation of "Buy" by AnalystsRead the original story

    Oct 20, 2015 | AmericanBankingNews.com

    ... needle-free delivery system. Sumavel DosePro provides the administration of sumatriptan for the acute treatment of migraine and cluster headache. The Organization sells Sumavel DosePro to wholesale pharmaceutical providers, pharmacies and hospitals. ...

    Comment?

  13. Jubilant Life Sciences gets USFDA nod for acute migraine drugRead the original story w/Photo

    Oct 20, 2015 | DNA India

    Jubilant Life Sciences has announced the receipt of approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine, Maxalt-MLT. Jubilant Life Sciences has announced the receipt of approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine, Maxalt-MLT.

    Comment?

  14. Investment Analysts' Recent Ratings Updates for ZogenixRead the original story

    Oct 16, 2015 | AmericanBankingNews.com

    ... Its first commercial product, Sumavel? DosePro? is a needle-free Delivery System used in the treatment of acute migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, ZX002, is a novel, oral and ...

    Comment?

  15. To your good health: Cycling vomiting may be abdominal migraineRead the original story w/Photo

    Oct 15, 2015 | SouthCoastToday.com

    ... normal health. Children have 12 cycles per year on average, while adults have four. CVS has been associated with migraine headaches, and treatment for migraines is sometimes successful in treating CVS, so it's possible CVS represents a variant of ...

    Comment?

  16. Zogenix Upgraded to "Strong-Buy" at ZacksRead the original story

    Oct 14, 2015 | AmericanBankingNews.com

    ... Its first commercial product, Sumavel? DosePro? is a needle-free Delivery System used in the treatment of acute migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate, ZX002, is a novel, oral and ...

    Comment?

  17. Zacks Downgrades Zogenix to HoldRead the original story

    Oct 13, 2015 | AmericanBankingNews.com

    According to Zacks, "Zogenix, Inc. is a pharmaceutical company engaged in the development and commercialization of treatment products for central nervous system disorders and pain. Its first commercial product, Sumavel? DosePro? is a needle-free Delivery System used in the treatment of acute migraine and cluster headache in a pre-filled, single-use delivery system.

    Comment?

  18. It's Not Just Hedge Fund Managers: Pharmacy Hikes the Price of Generic Drug 3000%Read the original story w/Photo

    Oct 13, 2015 | The Huffington Post

    ... chain pharmacy? Would they ever try to gouge a customer that much? Patricia Bernstein has suffered from migraine headaches since she was twelve years old. She often gets several migraines each month and, without treatment, her headaches can be ...

    Comment?

  19. Alder Biopharma Initiates Pivotal Clinical Trial Of ALD403 For...Read the original story

    Oct 12, 2015 | BioSpace

    First of Two Pivotal Trials Planned to Support Biologics License Application for ALD403 BOTHELL, Wash., Oct. 13, 2015 -- Alder BioPharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, Cushing's disease, Congenital Adrenal Hyperplasia and autoimmune and inflammatory diseases, today announced the initiation of the first of two planned pivotal clinical trials of ALD403, its transformative monoclonal antibody targeting the calcitonin gene-related peptide , for the prevention of frequent episodic migraine. CGRP is a small protein involved in the transmission of and heightened sensitivity to pain experienced in migraine.

    Comment?

  20. Precision injections of Botox into migraine 'centres'Read the original story w/Photo

    Oct 12, 2015 | Medical News Today

    Researchers are using a high-precision instrument to inject toxins that alleviate migraine attacks. This means even better needle guidance and user-friendliness.

    Comment?